Logo image of OLPX

OLAPLEX HOLDINGS INC (OLPX) Stock Fundamental Analysis

NASDAQ:OLPX - US6793691089 - Common Stock

1.4 USD
+0.06 (+4.48%)
Last: 8/22/2025, 8:00:02 PM
1.4 USD
0 (0%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

5

OLPX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 35 industry peers in the Personal Care Products industry. OLPX has only an average score on both its financial health and profitability. OLPX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year OLPX was profitable.
OLPX had a positive operating cash flow in the past year.
OLPX had positive earnings in each of the past 5 years.
Each year in the past 5 years OLPX had a positive operating cash flow.
OLPX Yearly Net Income VS EBIT VS OCF VS FCFOLPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of OLPX (-0.08%) is comparable to the rest of the industry.
OLPX's Return On Equity of -0.15% is in line compared to the rest of the industry. OLPX outperforms 51.43% of its industry peers.
OLPX's Return On Invested Capital of 2.54% is in line compared to the rest of the industry. OLPX outperforms 48.57% of its industry peers.
OLPX had an Average Return On Invested Capital over the past 3 years of 8.40%. This is significantly below the industry average of 13.70%.
The 3 year average ROIC (8.40%) for OLPX is well above the current ROIC(2.54%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.08%
ROE -0.15%
ROIC 2.54%
ROA(3y)6.34%
ROA(5y)7.22%
ROE(3y)13.59%
ROE(5y)18.06%
ROIC(3y)8.4%
ROIC(5y)9.93%
OLPX Yearly ROA, ROE, ROICOLPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 100 200 300 400

1.3 Margins

In the last couple of years the Profit Margin of OLPX has declined.
The Operating Margin of OLPX (10.97%) is better than 71.43% of its industry peers.
OLPX's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 70.81%, OLPX is doing good in the industry, outperforming 68.57% of the companies in the same industry.
In the last couple of years the Gross Margin of OLPX has declined.
Industry RankSector Rank
OM 10.97%
PM (TTM) N/A
GM 70.81%
OM growth 3Y-33.32%
OM growth 5Y-23.34%
PM growth 3Y-49.98%
PM growth 5Y-35.41%
GM growth 3Y-3.57%
GM growth 5Y-2.1%
OLPX Yearly Profit, Operating, Gross MarginsOLPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

OLPX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for OLPX has been increased compared to 1 year ago.
OLPX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OLPX has an improved debt to assets ratio.
OLPX Yearly Shares OutstandingOLPX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
OLPX Yearly Total Debt VS Total AssetsOLPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

OLPX has an Altman-Z score of 2.02. This is not the best score and indicates that OLPX is in the grey zone with still only limited risk for bankruptcy at the moment.
OLPX has a Altman-Z score of 2.02. This is in the lower half of the industry: OLPX underperforms 60.00% of its industry peers.
OLPX has a debt to FCF ratio of 3.63. This is a good value and a sign of high solvency as OLPX would need 3.63 years to pay back of all of its debts.
OLPX has a Debt to FCF ratio of 3.63. This is in the better half of the industry: OLPX outperforms 77.14% of its industry peers.
OLPX has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.40, OLPX perfoms like the industry average, outperforming 45.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 3.63
Altman-Z 2.02
ROIC/WACC0.31
WACC8.12%
OLPX Yearly LT Debt VS Equity VS FCFOLPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

OLPX has a Current Ratio of 3.86. This indicates that OLPX is financially healthy and has no problem in meeting its short term obligations.
OLPX has a Current ratio of 3.86. This is amongst the best in the industry. OLPX outperforms 82.86% of its industry peers.
A Quick Ratio of 3.20 indicates that OLPX has no problem at all paying its short term obligations.
OLPX has a better Quick ratio (3.20) than 82.86% of its industry peers.
Industry RankSector Rank
Current Ratio 3.86
Quick Ratio 3.2
OLPX Yearly Current Assets VS Current LiabilitesOLPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

OLPX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.86%.
Measured over the past years, OLPX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.10% on average per year.
The Revenue has decreased by -3.44% in the past year.
OLPX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.32% yearly.
EPS 1Y (TTM)-42.86%
EPS 3Y-54.93%
EPS 5Y-20.1%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-3.44%
Revenue growth 3Y-10.94%
Revenue growth 5Y23.32%
Sales Q2Q%2.25%

3.2 Future

Based on estimates for the next years, OLPX will show a decrease in Earnings Per Share. The EPS will decrease by -4.14% on average per year.
Based on estimates for the next years, OLPX will show a very strong growth in Revenue. The Revenue will grow by 29.95% on average per year.
EPS Next Y-44.36%
EPS Next 2Y-11.59%
EPS Next 3Y-4.14%
EPS Next 5YN/A
Revenue Next Year2.64%
Revenue Next 2Y2.87%
Revenue Next 3Y2.9%
Revenue Next 5Y29.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OLPX Yearly Revenue VS EstimatesOLPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
OLPX Yearly EPS VS EstimatesOLPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

OLPX is valuated rather expensively with a Price/Earnings ratio of 17.50.
Compared to the rest of the industry, the Price/Earnings ratio of OLPX indicates a somewhat cheap valuation: OLPX is cheaper than 80.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of OLPX to the average of the S&P500 Index (27.24), we can say OLPX is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 16.28, the valuation of OLPX can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OLPX indicates a somewhat cheap valuation: OLPX is cheaper than 77.14% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.82, OLPX is valued rather cheaply.
Industry RankSector Rank
PE 17.5
Fwd PE 16.28
OLPX Price Earnings VS Forward Price EarningsOLPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OLPX is valued a bit cheaper than the industry average as 68.57% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, OLPX is valued cheaper than 88.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.62
EV/EBITDA 10
OLPX Per share dataOLPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

OLPX's earnings are expected to decrease with -4.14% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.59%
EPS Next 3Y-4.14%

0

5. Dividend

5.1 Amount

OLPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OLAPLEX HOLDINGS INC

NASDAQ:OLPX (8/22/2025, 8:00:02 PM)

After market: 1.4 0 (0%)

1.4

+0.06 (+4.48%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners13.9%
Inst Owner Change0.01%
Ins Owners0.5%
Ins Owner Change39.4%
Market Cap933.91M
Analysts51.43
Price Target2.03 (45%)
Short Float %7.16%
Short Ratio8.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.18%
Min EPS beat(2)-32.11%
Max EPS beat(2)60.46%
EPS beat(4)2
Avg EPS beat(4)22%
Min EPS beat(4)-32.11%
Max EPS beat(4)69.03%
EPS beat(8)5
Avg EPS beat(8)16.36%
EPS beat(12)8
Avg EPS beat(12)10.16%
EPS beat(16)12
Avg EPS beat(16)10.46%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)1.35%
Max Revenue beat(2)3.89%
Revenue beat(4)3
Avg Revenue beat(4)2.54%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)12.38%
Revenue beat(8)6
Avg Revenue beat(8)1.96%
Revenue beat(12)7
Avg Revenue beat(12)-0.92%
Revenue beat(16)11
Avg Revenue beat(16)0.66%
PT rev (1m)-4.47%
PT rev (3m)0.54%
EPS NQ rev (1m)-7.5%
EPS NQ rev (3m)-42.89%
EPS NY rev (1m)-8.48%
EPS NY rev (3m)-5.26%
Revenue NQ rev (1m)-7.66%
Revenue NQ rev (3m)-7.93%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 17.5
Fwd PE 16.28
P/S 2.21
P/FCF 9.62
P/OCF 9.24
P/B 1.07
P/tB N/A
EV/EBITDA 10
EPS(TTM)0.08
EY5.71%
EPS(NY)0.09
Fwd EY6.14%
FCF(TTM)0.15
FCFY10.39%
OCF(TTM)0.15
OCFY10.83%
SpS0.63
BVpS1.31
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.08%
ROE -0.15%
ROCE 3.32%
ROIC 2.54%
ROICexc 3.2%
ROICexgc 54.14%
OM 10.97%
PM (TTM) N/A
GM 70.81%
FCFM 22.94%
ROA(3y)6.34%
ROA(5y)7.22%
ROE(3y)13.59%
ROE(5y)18.06%
ROIC(3y)8.4%
ROIC(5y)9.93%
ROICexc(3y)11%
ROICexc(5y)12.02%
ROICexgc(3y)125.03%
ROICexgc(5y)244.84%
ROCE(3y)11%
ROCE(5y)12.99%
ROICexcg growth 3Y-27.54%
ROICexcg growth 5Y-25.57%
ROICexc growth 3Y-37.52%
ROICexc growth 5Y-59.98%
OM growth 3Y-33.32%
OM growth 5Y-23.34%
PM growth 3Y-49.98%
PM growth 5Y-35.41%
GM growth 3Y-3.57%
GM growth 5Y-2.1%
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 3.63
Debt/EBITDA 3.53
Cap/Depr 7.58%
Cap/Sales 0.95%
Interest Coverage 0.85
Cash Conversion 101.42%
Profit Quality N/A
Current Ratio 3.86
Quick Ratio 3.2
Altman-Z 2.02
F-Score5
WACC8.12%
ROIC/WACC0.31
Cap/Depr(3y)7.27%
Cap/Depr(5y)5.1%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.53%
Profit Quality(3y)364.56%
Profit Quality(5y)302.34%
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3Y-54.93%
EPS 5Y-20.1%
EPS Q2Q%-33.33%
EPS Next Y-44.36%
EPS Next 2Y-11.59%
EPS Next 3Y-4.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.44%
Revenue growth 3Y-10.94%
Revenue growth 5Y23.32%
Sales Q2Q%2.25%
Revenue Next Year2.64%
Revenue Next 2Y2.87%
Revenue Next 3Y2.9%
Revenue Next 5Y29.95%
EBIT growth 1Y-49.69%
EBIT growth 3Y-40.62%
EBIT growth 5Y-5.47%
EBIT Next Year-15.89%
EBIT Next 3Y-2.97%
EBIT Next 5YN/A
FCF growth 1Y-51.1%
FCF growth 3Y-11.33%
FCF growth 5Y21.31%
OCF growth 1Y-50.02%
OCF growth 3Y-10.57%
OCF growth 5Y22.16%